Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature
Main Article Content
Keywords
2019 novel coronavirus, LAMP assay, Polymerase chain reaction (PCR), COVID-19, Point of care diagnostics (PoC)
Abstract
Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high-quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID19 in physician offices and other urgent healthcare-type settings and encourage academics and stakeholders towards advancement in order to control outbreaks and develop the public health surveillance system.
References
2. COVID-19 Health Advisory Platform by Ministry of National Health Services Regulations and Coordination [Internet]. [cited 2020 May 29]. Available from: http://covid.gov.pk/stats/pakistan.
3. Countries where Coronavirus has spread - Worldometer [Internet]. [cited 2020 May 29]. Available from: https://www.worldometers.info/coronavirus/countrieswhere-coronavirus-has-spread/.
4. CDC updates COVID-19 transmission webpage to clarify information about types of spread | CDC Online Newsroom | CDC [Internet]. [cited 2020 May 29]. Available from: https://www.cdc.gov/media/releases/2020/s0522-cdcupdates-covid-transmission.html.
5. Q&A on coronaviruses (COVID-19) [Internet]. [cited 2020 May 29]. Available from: https://www.who.int/emergencies/diseases/novel coronavirus-2019/question-and-answers-hub/qa-detail/q-a-coronaviruses.
6. Yang T, Wang Y, Shen C. Point-of-Care RNA-Based Diagnostic Device for COVID-19; 2020. p. 9-11 (Lcv).
7. Nguyen T, Bang DD, Wol A. 2019 Novel Coronavirus Disease ( COVID-19 ): Paving the Road for Rapid Detection and Point-of-Care Diagnostics; 2020. p. 1-7 (March).
8. Bendavid E, Mulaney B, Sood N, Shah S, Ling E, et al. COVID19 Antibody Seroprevalence in Santa Clara County, California. MedRxiv; 2020.
9. Mechanics A. A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry Mohamed El-Tholoth; 2019.
10. Lo S-J, Yang S-C, Yao D-J, Chen J-H, Tu W-C, Cheng C-M. Molecular-level dengue fever diagnostic devices made out of paper. Lab Chip. 2013;13(14):2686-92.
11. Paper O, Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 ( COVID-19 ) and other viral outbreaks; 2020. p. 39-45, 2019.
12. Lippi G, Plebani M. The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge. Diagnosis. 2020;7(2):79-81.
13. Reijn E, Swaan CM, Kretzschmar MEE, Van Steenbergen JE. Analysis of timeliness of infectious disease reporting in the Netherlands; 2011.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.